Pharma Pricing & Market Access Outlook Europe 22-25th March 2011

Main Category: Conferences
Also Included In: Pharma Industry / Biotech Industry
Article Date: 15 Mar 2011 - 6:00 PDT


Pharma Pricing & Market Access Outlook Europe 2011 is the leading policy forum on international pricing and reimbursement 22-25th March 2011

It is the world's largest gathering of pharmaceutical pricing, market access and reimbursement professionals and this year, with over 150 attendees, promises to be better than ever. We have leading experts from NICE UK, G-BA Germany, BlueCross BlueShield USA, HAS, GlaxoSmithKline, Cancer Care, Novartis and many more.

We asked Allen Korn, Senior Vice President, Chief Medical Officer, Sanofi-Aventis, who is presenting at Pharma Pricing & Market Access World 2011 for what he believes are the issues facing pharmaceutical market access, "Specialty Pharmacy medications with ever increasing price tags often inversely proportional to the value added, the rapidly expanding area of personalized medicine in the absence of any evidence that outcomes are improved or even, perhaps, worsened (needless anxiety, cascades of testing done as fishing-expeditions some of which inevitably lead to harms) and balancing access with sustainable affordability for our clients, a notion foreign to most pharmaceutical manufacturers". Allen Korn will be presenting the keynote presentation on 'US Healthcare Reform and Its Impact on Market Access' at next weeks event.

To see the full conference programme visit- http://www.healthnetworkcommunications.com/2011/pharmapricing

Other topics that will be addressed include:

Valuing new medicines and the future of value based pricing 

Patient access and flexible pricing schemes

Access to medicines in underserved markets

Pricing and market access in the major international markets 
 

To request a brochure or register call Sabrina on +44 (0) 207 608 7055.
Please quote MED01 as your valid voucher code.

• Additional
• References
• Citations